APA (7th ed.) Citation

Bell, J., Galaznik, A., Farrelly, E., Blazer, M., Seal, B., Ogbonnaya, A., . . . Faller, D. (2017). 136 - Survival Outcomes after First-Line Therapy in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Using a United States (US) Electronic Medical Record (EMR)-Based Cohort. Leukemia Research, 55, S84. https://doi.org/10.1016/S0145-2126(17)30249-7

Chicago Style (17th ed.) Citation

Bell, J., et al. "136 - Survival Outcomes After First-Line Therapy in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Using a United States (US) Electronic Medical Record (EMR)-Based Cohort." Leukemia Research 55 (2017): S84. https://doi.org/10.1016/S0145-2126(17)30249-7.

MLA (9th ed.) Citation

Bell, J., et al. "136 - Survival Outcomes After First-Line Therapy in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Using a United States (US) Electronic Medical Record (EMR)-Based Cohort." Leukemia Research, vol. 55, 2017, p. S84, https://doi.org/10.1016/S0145-2126(17)30249-7.